Health-tech company MediBuddy on Monday said it raised USD 20 million (about Rs 145 crore) earlier this month from India Life Sciences Fund III, LLC and others.
The company had announced an initial funding of USD 20 million in June last year under the series B round, a statement said.
"The additional infusion of USD 20 million led by India Life Sciences Fund III, LLC, with participation from other investors," it added.
The series B round has attracted new investments from India Life Sciences Fund III, LLC, TEAMFund LP, JAFCO Asia Fund, FinSight Ventures, ALES Global Japan and Beyond Next Ventures.
The round has also seen participation from existing investors including Bessemer Venture Partners, Milliways Ventures and Rebright Partners. The company has raised over USD 50 million so far.